Breast cancer
N Harbeck, F Penault-Llorca… - Nature reviews …, 2019 - mayoclinic.elsevierpure.com
Breast cancer is the most frequent malignancy in women worldwide and is curable in~ 70–
80% of patients with early-stage, non-metastatic disease. Advanced breast cancer with …
80% of patients with early-stage, non-metastatic disease. Advanced breast cancer with …
Sentinel lymph node mapping and staging in endometrial cancer: a Society of Gynecologic Oncology literature review with consensus recommendations
RW Holloway, NR Abu-Rustum, FJ Backes… - Gynecologic …, 2017 - Elsevier
The emphasis in contemporary medical oncology has been “precision” or “personalized”
medicine, terms that imply a strategy to improve efficacy through targeted therapies. Similar …
medicine, terms that imply a strategy to improve efficacy through targeted therapies. Similar …
Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology
WJ Gradishar, MS Moran, J Abraham, R Aft… - Journal of the National …, 2022 - jnccn.org
The therapeutic options for patients with noninvasive or invasive breast cancer are complex
and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include …
and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include …
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised …
Background We previously reported the 5-year results of the phase 3 IBCSG 23-01 trial
comparing disease-free survival in patients with breast cancer with one or more …
comparing disease-free survival in patients with breast cancer with one or more …
Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG …
AE Giuliano, KV Ballman, L McCall, PD Beitsch… - Jama, 2017 - jamanetwork.com
Importance The results of the American College of Surgeons Oncology Group Z0011
(ACOSOG Z0011) trial were first reported in 2005 with a median follow-up of 6.3 years …
(ACOSOG Z0011) trial were first reported in 2005 with a median follow-up of 6.3 years …
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
EC Rossi, LD Kowalski, J Scalici, L Cantrell… - The Lancet …, 2017 - thelancet.com
Background Sentinel-lymph-node mapping has been advocated as an alternative staging
technique for endometrial cancer. The aim of this study was to measure the sensitivity and …
technique for endometrial cancer. The aim of this study was to measure the sensitivity and …
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 …
M Donker, G van Tienhoven, ME Straver… - The lancet …, 2014 - thelancet.com
Background If treatment of the axilla is indicated in patients with breast cancer who have a
positive sentinel node, axillary lymph node dissection is the present standard. Although …
positive sentinel node, axillary lymph node dissection is the present standard. Although …
NCCN guidelines insights: breast cancer, version 1.2017
WJ Gradishar, BO Anderson, R Balassanian… - Journal of the national …, 2017 - jnccn.org
These NCCN Guidelines Insights highlight the important updates/changes to the surgical
axillary staging, radiation therapy, and systemic therapy recommendations for hormone …
axillary staging, radiation therapy, and systemic therapy recommendations for hormone …
Preservation of axillary lymph nodes compared with complete dissection in T1–2 breast cancer patients presenting one or two metastatic sentinel lymph nodes: the …
C Tinterri, D Gentile, W Gatzemeier, A Sagona… - Annals of surgical …, 2022 - Springer
Abstract Background The SINODAR-ONE trial is a prospective noninferiority multicenter
randomized study aimed at assessing the role of axillary lymph node dissection (ALND) in …
randomized study aimed at assessing the role of axillary lymph node dissection (ALND) in …
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial
JC Boughey, VJ Suman, EA Mittendorf, GM Ahrendt… - Jama, 2013 - jamanetwork.com
Importance Sentinel lymph node (SLN) surgery provides reliable nodal staging information
with less morbidity than axillary lymph node dissection (ALND) for patients with clinically …
with less morbidity than axillary lymph node dissection (ALND) for patients with clinically …